Oxidized amino acids: Culprits in human atherosclerosis and indicators of oxidative stress

Free Radical Biology and Medicine

Volumn 32, Issue 11, 2002, Pages 1090-1101

  Heinecke, Jay W ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Box 8046   (United States)

Author keywords

Atherosclerosis; Free radical; Hypochlorous acid; Low density lipoprotein; Myeloperoxidase; Oxidized LDL; Peroxynitrite; Tyrosyl radical

Indexed keywords

2,2' DITYROSINE; 3 (2 HYDROXYPHENYL)ALANINE; 4 HYDROXYNONENAL; ACETYLSALICYLIC ACID; ADVANCED GLYCATION END PRODUCT; ALPHA TOCOPHEROL; AMINO ACID; GLUCOSE; HEMOPROTEIN; HYDROXYL RADICAL; HYPOCHLOROUS ACID; ISOPROSTANE DERIVATIVE; LOW DENSITY LIPOPROTEIN; META TYROSINE; METAL ION; MYELOPEROXIDASE; NITRIC OXIDE; PEROXYNITRITE; PHENYLALANINE; RADICAL; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TYROSINE DERIVATIVE; TYROSYL RADICAL; UNCLASSIFIED DRUG; ANTIOXIDANT; METAL; PEROXIDASE;

AMINO ACID BLOOD LEVEL; AMINO ACID URINE LEVEL; ARTERY WALL; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DRUG EFFECT; DRUG EFFICACY; ENZYME INHIBITION; GAS CHROMATOGRAPHY; HUMAN; HYPERGLYCEMIA; ISOTOPE DILUTION ASSAY; MASS SPECTROMETRY; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PHAGOCYTE; PRIORITY JOURNAL; REVIEW; VITAMIN SUPPLEMENTATION; ARTERIOSCLEROSIS; LIPID PEROXIDATION; MASS FRAGMENTOGRAPHY; METABOLISM; OXIDATION REDUCTION REACTION;

AMINO ACIDS; ANTIOXIDANTS; ARTERIOSCLEROSIS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; LIPID PEROXIDATION; LIPOPROTEINS, LDL; METALS; NITRIC OXIDE; OXIDATION-REDUCTION; OXIDATIVE STRESS; PEROXIDASE;

EID: 0036591854     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(02)00792-X     Document Type: Article

References (113)

1. Koch's postulates for cholesterol
2. Role of oxidized low density lipoprotein in atherogenesis
3. The role of lipid peroxidation and antioxidants in oxidative modification of LDL
4. The role of oxidized lipoproteins in atherogenesis
5. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition
6. Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages
7. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: Recognition by receptors for acetylated low density lipoproteins
8. Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture
9. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation
10. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids
11. Isolation of low density lipoprotein from atherosclerotic vascular tissue of Watanabe Heritable Hyperlipidemic rabbits
12. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man
13. Malondialdehyde-altered protein occurs in atheroma of Watanabe Heritable hyperlipidemic rabbits
14. Distribution of oxidation specific lipid-protein adducts and apolipoprotein-B in atherosclerotic lesions of varying severity from WHHL rabbits
15. Clinical trials of antioxidants in atherosclerosis: Are we doing the right thing?
16. Antioxidants and atherosclerotic heart disease
17. Is the emperor wearing clothes? Clinical trials of vitamin E and the LDL oxidation hypothesis
18. Antioxidant defenses and lipid peroxidation in human blood plasma
19. Mechanisms of oxidative damage of low density lipoprotein in human atherosclerosis
20. Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for initiation of lipid peroxidation in low density lipoprotein
21. Alpha-tocopherol does not inhibit hypochlorite-induced oxidation of apolipoprotein B-100 of low-density lipoprotein
22. The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: A mechanism for producing advanced glycation end products at sites of inflammation
23. Increased atherosclerosis in myeloperoxidase-deficient mice
24. Mass spectrometry
25. Detecting oxidative modification of biomolecules with isotope dilution mass spectrometry: Sensitive and quantitative assays for oxidized amino acids in proteins and tissues
26. Artifact-free quantification of free 3-chlorotyrosine, 3-bromotyrosine, and 3-nitrotyrosine in human plasma by electron capture-negative chemical ionization gas chromatography/mass spectrometry and liquid chromatography-electrospray ionization tandem mass spectrometry
27. Protein oxidation and aging
28. NADPH oxidase of neutrophils elevates o,o′-dityrosine cross-links in proteins and urine during inflammation
29. Hydroxyl radical generation during exercise increases mitochondrial protein oxidation and levels of urinary dityrosine
30. Oxidized amino acids in the urine of aging rats: Potential markers for assessing oxidative stress in vivo
31. Mass spectrometric quantification of amino acid oxidation products in proteins: Insights into pathways that promote LDL oxidation in the human artery wall
32. Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells
33. Intact ceruloplasmin oxidatively modifies low density lipoprotein
34. Role of endogenous ceruloplasmin in low density lipoprotein oxidation by human U937 monocytic cells
35. Hemin: A possible physiological mediator of low density lipoprotein oxidation and endothelial injury
36. Stimulation of lipid peroxidation and hydroxyl radical generation by the contents of human atherosclerotic lesions
37. Prooxidant iron and copper, with ferroxidase and xanthine oxidase activity in human atherosclerotic material
38. Transition metals within human atherosclerotic lesions can catalyze the oxidation of low density lipoprotein by macrophages
39. The specific binding of iron (III) and copper (II) to transferrin and conalbumin
40. The influence of medium components on Cu-dependent oxidation of low density lipoproteins and its sensitivity to superoxide dismutase
41. Copper-binding properties of bovine serum albumin and its amino-terminal peptide fragment
42. The biology of oxygen radicals
43. Formation of o-tyrosine and dityrosine in proteins during radiolytic and metal-catalyzed oxidation
44. Mass spectrometric quantification of markers for protein oxidation by tyrosyl radical, copper, and hydroxyl radical in low density lipoprotein isolated from human atherosclerotic plaques
45. Are body iron stores related to the risk of coronary heart disease?
46. Hemochromatosis, multiorgan hemosiderosis, and coronary artery disease
47. Effect of iron overload and iron deficiency on atherosclerosis in the hypercholesterolemic rabbit
48. Iron overload diminishes atherosclerosis in apoE-deficient mice
49. Disorders of copper transport
50. Chronic hyperglycemia increases arterial low-density lipoprotein metabolism and atherosclerosis in cynomolgus monkeys
51. A hydroxyl radical-like species oxidizes cynomolgus monkey artery wall proteins in early diabetic vascular disease
52. Role of oxidative stress in diabetic complications: A new perspective on an old paradigm
53. Protein aging by carboxymethylation of lysines generates sites for divalent metal and redox active copper binding: Relevance to diseases of glycoxidative stress
54. Free radicals generated during the glycation reaction of amino acids by methylglyoxal
55. Oxidation-reduction properties of methylglyoxal-modified protein in relation to free radical generation
56. Oxidative chemistry of peroxynitrite
57. Nitric oxide: Physiology, pathophysiology and pharmacology
58. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide
59. Peroxynitrite modifications of LDL leads to recognition by the macrophage scavenger receptor
60. Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerosis
61. The participation of nitric oxide in cell free and its restriction of macrophage-mediated oxidation of low-density lipoprotein
62. A protective role for nitric oxide in the oxidative modification of low density lipoprotein by mouse macrophages
63. Inhibition of low-density lipoprotein oxidation by nitric oxide: Potential role in atherogenesis
64. Nitric oxide inhibition of lipoxygenase-dependent liposome and low-density lipoprotein oxidation: Termination of radical chain propagation reactions and formation of nitrogen-containing oxidized lipid derivatives
65. Action of nitric oxide as an antioxidant against oxidation of soybean phosphatidylcholine liposomal membranes
66. Is NO an endogenous antiatherogenic molecule?
67. L-arginine prevents xanthoma development and inhibits atherosclerosis in LDL receptor knockout mice
68. Genetic deficiency of inducible nitric oxide synthase reduces atherosclerosis and lowers plasma lipid peroxides in apolipoprotein E-knockout mice
69. Enhanced atherosclerosis and kidney dysfunction in eNOS(-/-)Apoe(-/-) mice are ameliorated by enalapril treatment
70. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry
71. Oxygen metabolism and the toxic properties of phagocytes
72. Leukocytic oxygen activation and microbicidal oxidative toxins
73. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions
74. Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes
75. Studies on the chlorinating activity of myeloperoxidase
76. Oxidation of low-density lipoprotein with hypochlorite causes transformation of lipoprotein into a high-uptake form for macrophages
77. Human neutrophils employ chlorine gas as an oxidant during phagocytosis
78. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima
79. Neutrophils employ the myeloperoxidase system to generate antimicrobial brominating and chlorinating oxidants during sepsis
80. Dityrosine, a specific marker of oxidation, is synthesized by the myeloperoxidase-hydrogen peroxide system of human neutrophils and macrophages
81. Electron paramagnetic resonance detection of free tyrosyl radical generated by myeloperoxidase, lactoperoxidase, and horseradish peroxidase
82. Higher oxidation states of prostaglandin H synthase
83. Tyrosyl radical generated by myeloperoxidase catalyzes the oxidative cross-linking of proteins
84. Oxidative tyrosylation of high density lipoprotein by peroxidase enhances cholesterol removal from cultured fibroblasts and macrophage foam cells
85. Brominating oxidants generated by human eosinophils
86. Association between myeloperoxidase levels and risk of coronary artery disease
87. Formation of nitrating and chlorinating species by reaction of nitrite with hypochlorous acid: A novel mechanism for nitric oxide-mediated protein modification
88. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils
89. 8-Nitro-2′-deoxyguanosine, a specific marker of oxidation by reactive nitrogen species, is generated by the myeloperoxidase-hydrogen peroxide-nitrite system of activated human phagocytes
90. Nitrogen dioxide radical generated by the myeloperoxidase-hydrogen peroxide-nitrite system promotes lipid peroxidation of low density lipoprotein
91. Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro
92. Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycolaldehyde, 2-hydroxypropanal, and acrolein. A mechanism for the generation of highly reactive alpha-hydroxy and alpha,beta-unsaturated aldehydes by phagocytes at sites of inflammation
93. Modification of low density lipoprotein with 4-hydroxynonenal induces uptake by macrophages
94. Scavenger receptor-independent stimulation of cholesterol esterification in macrophages by low density lipoprotein extracted from human aortic intima
95. Specificity of receptor-mediated recognition of malondialdehyde-modified low density lipoproteins
96. Recognition of oxidized low density lipoprotein by the scavenger receptor of macrophages results from derivatization of apolipoprotein B by products of fatty acid peroxidation
97. Mechanism of uptake of copper-oxidized low density lipoprotein in macrophages is dependent on its extent of oxidation
98. Dityrosine and tyrosine oxidation products are endogenous markers for the selective proteolysis of oxidatively modified red blood cell hemoglobin by (the 19 S) proteasome
99. Reversible blockade of the respiratory burst in human neutrophils by a cleavable cross-linking agent
100. Phagocytes and oxidative stress
101. Human phagocytes employ the myeloperoxidase-hydrogen peroxide system to synthesize dityrosine, trityrosine, pulcherosine, and isodityrosine by a tyrosyl radical-dependent pathway
102. Production of brominating intermediates by myeloperoxidase. A transhalogenation pathway for generating mutagenic nucleobases during inflammation
103. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS)
104. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico
105. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators
106. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group
107. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): Randomised placebo-controlled trial
108. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease
109. Low-dose aspirin and vitamin E in people at cardiovascular risk: A randomised trial in general practice. Collaborative Group of the Primary Prevention Project
110. Effects of vitamin E on lipid peroxidation in healthy persons
111. Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase
112. Molecular action of vitamin E in lipoprotein oxidation: Implications for atherosclerosis